A recent report from the Centers for Medicare and Medicaid Services (CMS) predicted that the average growth in national healthcare spending would outpace average gross domestic product (GDP) growth from 2022 to 2031, at 5.4% and 4.6%, respectively. Per person spending is also expected to increase to an annual rate of 4.8% from 2022 to 2031. This is above pre-COVID-19-pandemic growth rates for per person spending, which averaged 3.9% per capita between 2014 and 2019. CMS anticipated that the growth in national and per person healthcare spending would contribute to an increase in the healthcare spending share of the GDP.
Report Findings
Prior to the COVID-19 pandemic, healthcare spending constituted about 17.6% of the GDP. This share rose to 19.7% in 2020when healthcare spending increased and the overall economy slowed. In 2021 and 2022, this trend reversed as healthcare spending grew slower than the GDP, accounting for 18.3% and 17.4% of total expenditures, respectively. However, beginning in 2023, health spending is expected to grow faster than the economy, reaching 19.6% of the GDP by 2031.
Out-of-pocket spending rose 10.3% in 2021 as care resumed after the first year of the pandemic. According to CMS, out-of-pocket spending grew 3.8% per capita in 2022 and 4.4% per capita in 2023. However, CMS actuaries predict that growth in out-of-pocket spending will moderate, dropping to an average of 3.4% per capita for the following seven years.
According to CMS, prescription drug spending grew 7.7% per capita from 2020 to 2021. Increases in Medicaid prescription drug spending and Medicaid enrollment drove per capita prescription drug spending growth during the pandemic. Growth in drug spending is expected to slow to 2.8% per capita in 2023 as Medicaid enrollment declines and Medicare prescription drug spending decreases due to generic drugs entering the market in some drug categories and the Inflation Reduction Act reform stake effect.
Employer Takeaways
As health costs continue to rise, employees will continue to look to their employers for assistance. This can create challenges for employers, many of whom are already struggling with the rising cost of medical coverage for employees. Consequently, employers may need to evaluate their benefits plans for cost-saving measures that can meet budget requirements without sacrificing highly desired employee benefits.
For more employee benefits resources and industry insights, contact INSURICA today.
Copyright © 2023 Smarts Publishing. This is not intended to be exhaustive nor should any discussion or opinions be construed as legal advice. Readers should contact legal counsel or an insurance professional for appropriate advice.
About the Author
Share This Story
Related Blogs
The Expanding Role of AI in Education
Artificial intelligence is quickly becoming part of the modern [...]
Fiduciary Responsibilities for Employer Health Plans: What Employers Should Know Now
When employers think about fiduciary responsibility, retirement plans often come to mind first. But recent developments make it clear that fiduciary duties also matter—sometimes significantly—when it comes to employer-sponsored health and welfare plans.
The New Era of Mental Health Parity Enforcement in 2026
Federal agencies have made mental health parity enforcement a top priority in 2026, and employers sponsoring group health plans are feeling the impact. Regulators are no longer satisfied with high‑level assurances that plans comply with the Mental Health Parity and Addiction Equity Act (MHPAEA). Instead, they expect detailed, data‑driven documentation showing that mental health and substance‑use‑disorder benefits are truly comparable to medical and surgical benefits. This includes not only the written plan design but also how rules are applied in real‑world scenarios.









